^^^

"The results were incredible. They saw unheard-of cure rates in both artificially infected and naturally infected cats (between 80% and 100%). It seemed like the problem had been solved.

 

"Unfortunately, Gilead Sciences reportedly refused to license GS-441524, the simpler of the two molecules, for use in cats, and they later pursued Remdesivir as a treatment for severely ill COVID-19 patients."